MMP2 and esophageal squamous cell carcinoma: Here, we confirmed the Cisplatin-induced expression of ATF3 via P53 and further showed that Cisplatin might suppress the invasion of ESCC cells by targeting the ATF3/MDM2/MMP-2 complex, suggesting that ATF3 is a potential treatment target in the chemotherapy of ESCC.